Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Role of the MTHFR polymorphisms in cancer risk modification and treatment.

Future oncology (London, England) - 1 May 2009

Kim Young-In

Abstract excerpt

The role of folate, a water-soluble B vitamin, and single nucleotide polymorphisms (SNPs) in the folate metabolic pathway in human health and disease has been rapidly expanding. Recently, functionally significant SNPs in 5,10-methylenetetrahydrofolate reductase (MTHFR), a critical enzyme for intracellular folate homeostasis and metabolism, have been identified and characterized. The MTHFR SNPs are ideal...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Drug Resistance, Neoplasm
Share to Fluorouracil

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Folic Acid

Share to Methotrexate

Share to Methylenetetrahydrofolate Reductase (NADPH2)

Share to Neoplasms

Share to Risk Factors

Source

Identifiers

PMID: 19450180
DOI: 10.2217/fon.09.26

Genes

MTHFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Role of the MTHFR polymorphisms in cancer risk modification and treatment.PMID 19450180Read ↗

5,10-Methylenetetrahydrofolate reductase polymorphisms and pharmacogenetics: a new role of single nucleotide polymorphisms in the folate metabolic pathway in human health and disease.Semantic proximity Read ↗

Pharmacogenetic relevance of MTHFR polymorphisms.Semantic proximity Read ↗

A literature review of MTHFR (C677T and A1298C polymorphisms) and cancer risk.Semantic proximity Read ↗

MTHFR Gene Polymorphisms: A Single Gene with Wide-Ranging Clinical Implications—A ReviewSemantic proximity Read ↗

Effect of the methylenetetrahydrofolate reductase C677T polymorphism on chemosensitivity of colon and breast cancer cells to 5-fluorouracil and methotrexate.Semantic proximity Read ↗

Methylenetetrahydrofolate reductase, common polymorphisms, and relation to disease.Semantic proximity Read ↗

MTHFR Gene Polymorphisms: A Single Gene with Wide-Ranging Clinical ImplicationsSemantic proximity Read ↗

MTHFR C677T and A1298C Polymorphisms in Breast Cancer, Gliomas and Gastric Cancer: A Review.Semantic proximity Read ↗

Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism: epidemiology, metabolism and the associated diseases.Semantic proximity Read ↗

Polymorphisms in the methylenetetrahydrofolate reductase gene: clinical consequences.Semantic proximity Read ↗

The methylenetetrahydrofolate reductase C677T mutation induces cell-specific changes in genomic DNA methylation and uracil misincorporation: a possible molecular basis for the site-specific cancer risk modification.Semantic proximity Read ↗

Effect of Genetic Polymorphisms in the Folate Pathway on Methotrexate Therapy in Rheumatic DiseasesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.